Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) announces today that the number of shares and votes in Xspray Pharma AB has changed as a result of the exercise of warrants under the company's incentive programs.
Through the exercise of warrants under the company's incentive program, LTIP 2015/2021, the number of outstanding shares and votes has increased by 175,000 to 19,067,504. The share capital has increased by SEK 175,000 from SEK 18,892,504 to SEK 19,067,504.
With reference to the press release on August 21, the shares now registered are part of the total number of warrants that have been exercised to subscribe for shares. The LTIP 2015/2021 warrant program has now been terminated and the company announces that all warrant holders have exercised their opportunity to subscribe for shares.